Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/17961
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, KC | - |
dc.contributor.author | Padget, K | - |
dc.contributor.author | Curtis, H | - |
dc.contributor.author | Cowell, IG | - |
dc.contributor.author | Moiani, D | - |
dc.contributor.author | Sondka, Z | - |
dc.contributor.author | Morris, NJ | - |
dc.contributor.author | Jackson, GH | - |
dc.contributor.author | Cockell, SJ | - |
dc.contributor.author | Tainer, JA | - |
dc.contributor.author | Austin, CA | - |
dc.date.accessioned | 2019-04-29T14:07:08Z | - |
dc.date.available | 2012-09-15 | - |
dc.date.available | 2019-04-29T14:07:08Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Biology Open, 2012, 1 (9), pp. 863 - 873 | en_US |
dc.identifier.issn | http://dx.doi.org/10.1242/bio.20121834 | - |
dc.identifier.issn | 2046-6390 | - |
dc.identifier.issn | http://dx.doi.org/10.1242/bio.20121834 | - |
dc.identifier.issn | 2046-6390 | - |
dc.identifier.uri | http://bura.brunel.ac.uk/handle/2438/17961 | - |
dc.description.abstract | Topoisomerase II creates a double-strand break intermediate with topoisomerase covalently coupled to the DNA via a 59phosphotyrosyl bond. These intermediate complexes can become cytotoxic protein-DNA adducts and DSB repair at these lesions requires removal of topoisomerase II. To analyse removal of topoisomerase II from genomic DNA we adapted the trapped in agarose DNA immunostaining assay. Recombinant MRE11 from 2 sources removed topoisomerase IIa from genomic DNA in vitro, as did MRE11 immunoprecipitates isolated from A-TLD or K562 cells. Basal topoisomerase II complex levels were very high in A-TLD cells lacking full-length wild type MRE11, suggesting that MRE11 facilitates the processing of topoisomerase complexes that arise as part of normal cellular metabolism. In K562 cells inhibition of MRE11, PARP or replication increased topoisomerase IIa and b complex levels formed in the absence of an anti-topoisomerase II drug. | en_US |
dc.description.sponsorship | This work was funded by LRF grant 04037 and LLR grant 07038 (K.C.L., K.P., H.C., I.G.C., Z.S., G.H.J., N.J.M., S.J.C. and C.A.A.). The efforts of D.M. and J.A.T. on Mre11 mutant preparations were supported by National Cancer Institute grant CA117638 (J.A.T.). | en_US |
dc.format.extent | 863 - 873 | - |
dc.language.iso | en | en_US |
dc.publisher | Published by The Company of Biologists Ltd | en_US |
dc.subject | Topoisomerase II | en_US |
dc.subject | MRE11 | en_US |
dc.subject | DSB repair | en_US |
dc.subject | Protein-DNA adducts | en_US |
dc.title | MRE11 facilitates the removal of human topoisomerase II complexes from genomic DNA | en_US |
dc.type | Article | en_US |
dc.identifier.doi | http://dx.doi.org/10.1242/bio.20121834 | - |
dc.relation.isPartOf | Biology Open | - |
pubs.issue | 9 | - |
pubs.publication-status | Published | - |
pubs.volume | 1 | - |
dc.identifier.eissn | 2046-6390 | - |
Appears in Collections: | Dept of Life Sciences Research Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
FullText.pdf | 875.08 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.